1.Prochazkova, L, Parkes, L, Dawson, Aet al. Unpacking the role of self-reported compulsivity and impulsivity in obsessive-compulsive disorder. CNS Spectr. 2018; 23(1): 51–58.
2.Grassi, G, Figee, M, Ooms, Pet al. Impulsivity and decision-making in obsessive-compulsive disorder after effective deep brain stimulation or treatment as usual. CNS Spectr. 2018; 4: 1–7.
3.Grassi, G, Pallanti, S, Righi, Let al. Think twice: impulsivity and decision making in obsessive-compulsive disorder. J Behav Addict. 2015; 4(4): 263–272.
4.Benatti, B, Dell’Osso, B, Arici, Cet al. Characterizing impulsivity profile in patients with Obsessive-Compulsive Disorder. Int J Psychiatry Clin Pract. 2014; 18(3): 156–160.
5.Figee, M, Vink, M, de Geus, Fet al. Dysfunctional reward circuitry in obsessive-compulsive disorder. Biol Psychiatry. 2011; 69(9): 867–874.
6.Cavedini, P, Zorzi, C, Piccini, Met al. Executive dysfunctions in obsessive-compulsive patients and unaffected relatives: searching for a new intermediate phenotype. Biol Psychiatry. 2010; 67(12): 1178–1184.
7.Chamberlain, SR, Fineberg, NA, Menzies, LAet al. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007; 164(2): 335–338.
8.Denys, D.Obsessionality and compulsivity: a phenomenology of obsessive compulsive disorder. Philosophy, Ethics, and Humanities in Medicine. 2011; 6: 3.
9.Ferreira, GM, Yücel, M, Dawson, Aet al. Investigating the role of anticipatory reward and habit strength in obsessive-compulsive disorder. CNS Spectr. 2017; 9: 1–10.
10.Grant, JE, Odlaug, BL, Chamberlain, SR.Neural and psychological underpinnings of gambling disorder: a review. Prog Neuropsychopharmacol Biol Psychiatry. 2016; 65: 188–193.
11.First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
12.First, MB, Gibbon, M, Spitzer, RLet al. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington, DC: American Psychiatry Press Inc; 1997.
13.First, MB, Spitzer, RL, Gibbon, Met al. Structured Clinical Interview for DSM-IV TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
14.Goodman, WK, Price, LH, Rasmussen, SAet al. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), part I: development, use, and reliability. Arch Gen Psychiatry. 1898; 46: 1006–1011.
15.Goodman, WK, Price, LH, Rasmussen, SAet al. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), part II: validity. Arch Gen Psychiatry. 1989; 46: 1012–1016.
16.Pallanti, S, DeCaria, CM, Grant, JEet al. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). J Gambl Stud. 2005; 21(4): 431–443.
17.Brakoulias, V, Starcevic, V, Berle, Det al. Further support for five dimensions of obsessive- compulsive symptoms. J Nerv Ment Dis. 2013; 201: 452–459.
18.Hamilton, M.The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32: 50–55.
19.Hamilton, M.Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6(4): 278–296.
20.Sartori, G, Colombo, L, Vallar, Get al. T.I.B.: Test di Intelligenza Breve per la valutazione del quoziente intellettivo attuale e pre-morboso. La Professione di Psicologo. 1997; 1: II–XXIV.
21.Heatherton, TF, Kozlowski, LT, Frecker, RCet al. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991; 86: 1119–1127.
22.Patton, JH, Stanford, MS, Barratt, ES.Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol. 1995; 51: 768–774.
23.Fossati, A, Di Ceglie, A, Acquarini, Eet al. Psychometric properties of an Italian version of the Barratt Impulsiveness Scale-11 (BIS-11) in nonclinical subject. J Clin Psychol. 2001; 57: 815–828.
24.Brand, M, Labudda, K, Markowitsch, Het al. Neuropsychological correlates of decision-making in ambiguous and risky situations. Neural Netw. 2007; 19: 1266–1276.
25.Brand, M, Recknor, EC, Grabenhorst, Fet al. Decision under ambiguity and decision under risk: Correlations with executive functions and comparisons of two different gambling tasks with implicit and explicit rules. J Clin Exp Neuropsychol. 2007; 29(1): 86–99.
26.Cavedini, P, Zorzi, C, Baraldi, Cet al. The somatic marker affecting decisional processes in obsessive-compulsive disorder. Cognitive Neuropsychiatry. 2012; 17(2): 177–190.
27.Bechara, A, Damasio, AR, Damasio, Het al. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994; 50: 7–15.
28.Struglia, F, Stratta, P, Gianfelice, Det al. Decision making impairment in schizophrenia: relationships with positive symptomatology. Neurosci Lett. 2011; 502: 80–83.
29.Tomassini, AR, Struglia, F, Spaziani, Det al. Decision making, impulsivity and personality traits in alcohol dependent subjects. Am J Addict. 2012; 21: 263–267.
30.Anderson, AK, Christoff, K, Stappen, Iet al. Dissociated neural representations of intensity and valence in human olfaction. Nature Neuroscience. 2003; 6(2): 196–202.
31.Fagundo, AB, Jiménez-Murcia, S, Giner-Bartolomé, Cet al. Modulation of higher-order olfaction components on executive functions in humans. PLoS One. 2015; 10(6): e0130319.
32.Mesholam-Gately, RI, Gibson, LE, Seidman, LJet al. Schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine. Schizophrenia Res. 2014; 155(1–3): 45–51.
33.Snaith, RP, Hamilton, M, Morley, Set al. A scale for the assessment of the hedonic tone: the Snaith-Hamilton Pleasure Scale. British J Psych. 1995; 167: 99–103.
34.Santangelo, G, Morgante, L, Savica, Ret al. Anhedonia and cognitive impairment in Parkinson’s disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. Parkinsonism Relat Disord. 2009; 15(8): 576–581.
35.Steinbach, S, Hummel, T, Böhner, Cet al. Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol. 2009; 27(11): 1899–1905.
36.Ettelt, S, Ruhrmann, S, Barnow, Set al. Impulsiveness in obsessive-compulsive disorder: results from a family study. Acta Psychiatrica Scandinavica. 2007; 115(1): 41–47.
37.Chowdhury, NS, Livesey, EJ, Blaszczynski, Aet al. Pathological gambling and motor impulsivity: a systematic review with meta-analysis. J Gambl Stud. 2017; 33(4): 1213–1239.
38.Kovács, I, Richman, MJ, Janka, Zet al. Decision making measured by the Iowa Gambling Task in alcohol use disorder and gambling disorder: a systematic review and meta-analysis. Drug Alcohol Depend. 2017; 181: 152–161.
39.Zhang, L, Dong, Y, Ji, Yet al. Trait-related decision-making impairment in obsessive-compulsive disorder: evidence from decision making under ambiguity but not decision making under risk. Sci Rep. 2015; 5:1731–1732.
40.Abramovitch, A, Pizzagalli, DA, Reuman, Let al. Anhedonia in obsessive-compulsive disorder: beyond comorbid depression. Psychiatry Res. 2014; 216(2): 223–229.
41.Luijten, M, Schellekens, AF, Kühn, Set al. Disruption of reward processing in addiction: an image-based meta-analysis of functional magnetic resonance imaging studies. JAMA Psychiatry. 2017; 74(4): 387–398.
42.Denys, D, Mantione, M, Figee, Met al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2010; 67(10): 1061–1068.
43.Figee, M, Luigjes, J, Smolders, Ret al. Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder. Nat Neurosci. 2013; 16(4): 386–387.
44.Pallanti, S, Marras, A, Grassi, G.Outcomes with Neuromodulation in obsessive-compulsive disorder. Psychiatric Annals. 2015; 45(6): 316–320
45.Pallanti, S, Marras, A, Salerno, Let al. Better than treated as usual: transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial. J Psychopharmacol. 2016; 30(6): 568–578.
46.Pallanti, S, Hollander, E.Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity. CNS Spectr. 2014; 19(1): 50–61.